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Abstract: Patients who received kidney transplantation, vitamin D deficiency is probable due to deficient sun
exposure  and  the  lag  between transplant and normal kidney function. In this study, serum level of vitamin
D was assessed in patients with kidney transplantation and normal population. All transplant patients in 5 Azar
hospital and clinics of Gorgan were recruited. The results show that among kidney transplant receivers and
control subjects, 55.1% and 2% had significantly 25-hydroxyvitamin D deficiency, 42.9% and 63.3%
significantly 25-hydroxyvitamin D insufficiency, respectively. In kidney transplant receivers, there was one
person with normal 25-hydroxyvitamin D level. The time passed from the transplantation had no significant
effects on serum level of vitamin D and was lower in those with higher time passed. It could be concluded that
there  is high  prevalence of 25-hydroxyvitamin D insufficiency and deficiency after kidney transplantation
(98% of our patients), without considering of transplantation time. In accord with recent informs, we suggest
it very necessary that status of vitamin D deficiency/insufficiency are corrected in kidney transplant patients.
Hence, supplementing of vitamin D appeared to be the only possible ways of making better and correcting
vitamin D status in kidney transplant receivers.
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INTRODUCTION transplantation, the risk of vitamin D deficiency is
Vitamin D is a steroid hormone and shows a from exposure to sunshine for protection from skin cancer.
significant  role  in calcium metabolism. Levels of serum Therefore, the increasing of risk of vitamin D deficiency in
25-hydroxyvitamin  D  express storages of body vitamin these patients may happen. One of the standard treatment
D and are used as an amount of vitamin D position in the alternatives  in patients with end stage renal disease at
body [1]. There are limited sources of vitamin D in Natural this  moment  is  Kidney   transplantation,   which  can
dietary, foods like fish and to a lesser degree meat, eggs, give  chances  for  all  patients  [5, 6]. Measurements of
milk and dairy products are sources of vitamin D [2]. 25-hydroxyvitamin D levels before kidney transplant
Deficiency of vitamin D is collaborated with elevated risk revealed just approximately15% of kidney transplant
of cancer, type 1 diabetes mellitus, multiple sclerosis and receivers have sufficient  vitamin D levels at the time of
cardiovascular  unhealthiness  in  the number of people transplantation [7, 8]. Vitamin D deficiency stays a usual
[3-4]. Vitamin D deficiency is very common in the number difficulty after kidney transplantation in kidney transplant
of people of the United States and in some countries that receivers. They are informed to keep away from direct sun
they  are  far  from the equator with limited sunshine [4]. exposure. There is high risk of skin cancer in these
In People with chronic kidney disease or a person after patients [9]. Study of Querings et al. in 31 kidney
elevated. Kidney transplant receivers must keep away
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transplant receivers showed that serum 25 hydroxyvitamin kidney transplant receivers and in the control subjects
D levels were significantly lower in kidney transplant were compared using a Chi square, t-test and linear
receivers when compared with an age- and sex-matched regression analysis. P < 0.05 was considered significant.
control subject [10]. Study of Stavroulopoulos et al.
showed that insufficient amount of serum 25- RESULTS
hydroxyvitamin D to be present in 43%, deficiency in 46%
and severe deficiency in 5% kidney transplant receivers The mean age of the patients and control subjects
[11]. The National Kidney Foundation has carefully were 35.59 ±10.4 and 35.06 ±13.4 years, respectively. A
planned clinical practice programs that imply that number of obvious differences between the two subjects
measurement of 25-hydroxyvitamin D is significant in is found. Data of Table 1 shows that the kidney transplant
patients with chronic kidney disease [12]. In chronic receivers are significantly lowers 25-hydroxyvitamin D
kidney disease patients, the prevalence of 25- than control subjects (P< 0.05). It was about one third in
hydroxyvitamin D deficiency and insufficiency is high and transplant patients. There was no significant difference in
it is variable from70% to 80%, without considering of BMI in kidney transplant receivers and control subjects.
geographic locality [13, 14]. Increased risk for bone Data of Table 1 shows that among kidney transplant
disease and other diseases like colon, prostate and breast receivers and control subjects, 55.1% and 2% had
cancer  is  also  collaborated with vitamin D deficiency significantly 25-hydroxyvitamin D deficiency, 42.9% and
[15-17], because of these effects, it is necessary to screen 63.3% significantly 25-hydroxyvitamin D insufficiency,
for vitamin  D deficiency in kidney transplant patients respectively.  In kidney transplant receivers, there was
[18-20].  The present study aimed to assess the level of one person with normal 25-hydroxyvitamin D level. The
25-hydroxyvitamin D in patients with kidney time passed from the transplantation had no significant
transplantation in Gorgan (South East of Caspian Sea), effects on serum level of vitamin D and was lower in those
Iran. with higher time passed. There was no correlation
MATERIALS AND METHODS age and BMI in kidney transplant receivers (Table 2).
In this cross-sectional study, all transplant patients DISCUSSION
(49 adults) in 5  Azar Hospital and clinics of Gorgan wereth
recruited. There were 18 males and 31 females kidney This  study  was  planned  to  examine the levels of
transplant receivers and 4 males and 45 females control 25-hydroxyvitamin D in the kidney transplant receivers
subjects  respectively. The transplantation time was less and compared it with healthy subjects. The most of
and more than 5 years respectively. The control subjects kidney receivers had low 25-hydroxyvitamin D levels:
were healthy blood donors who referred to Gorgan blood 55.1% showed a deficiency and 42.9% had an
transfusion center. Blood samples were obtained from insufficiency. The healthy subjects had 25-
both groups. Kidney transplant receivers had not been hydroxyvitamin D levels: 2% showed a deficiency and
treated with Insulin, vitamin D and they had no history of 63.3% had an insufficiency. Our results are almost the
hepatic disorder, acute illness, life-threatening, any other same as reported by those studied from England by
competitive illness, mental disorders and severe Stavroulopoulus  et al.  [11],  in  such  a  way  94%  had
malabsorption. Serum 25-hydroxyvitamin D levels in 25-hydroxyvitamin D deficiency or insufficiency.
kidney transplant receivers were analyzed and compared Additionally, serum levels of 25-hydroxyvitamin D in our
with an  age-  and  sex-matched control subjects. Serum kidney transplant receivers were lower than those studied
25 hydroxyvitamin D levels were assessed with Elisa kit among healthy subjects. Our results recommended that
both in kidney transplant receivers and in the control vitamin D deficiency/insufficiency is nearly general, which
subjects. BMI was calculated as weight in kilograms is influencing number of people and also the kidney
divided by height in meters squared [21]. The results of transplant receivers. Studies of Querings 10, Boudville
serum 25OHD  analyzing   were   stratified   as  follows: [22] and Marecen et al. [23] showed that kidney
25-hydroxyvitamin D deficiencies (<25 nmol/mL) or transplant receivers had higher level of 25-hydroxyvitamin
insufficiency (25-75 nmol/mL) or normal (76-250 nmol/mL), D deficiency or insufficiency when compared with
according to Elisa kit. Data are presented as means±SD healthy subjects. Our results are in agreement with the
and percentiles. Serum levels of 25-hydroxyvitamin D in findings   of  some  other studies [10, 22-23]. Additionally,
between 25-hydroxyvitamin D and transplantation time,
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Table 1: Comparison of serum 25-hydroxyvitamin D between kidney transplant receivers and control subjects
Parameters Kidney transplant receivers (n=49) Healthy subjects (n=49)
Age (years) 35.59±10.4 35.06±13.6
Gender
Males, n (%) 31 (63. 3%) 45 (91.8%)
Females, n (%) 18 (36.7%) 4 (8.2%)
BMI (kg/m²) 23.55±36.8 23.82±36.9
Serum 25(OH) D (nmol/ml) 19.23±27.63* 52.76±78.49
Serum 25(OH) D
Deficiency, n (%) 27 (55.1%)* 1 (2%)
Insufficiency, n (%) 21 (42.9%)* 31 (63.3%)
Normal, n (%) 1 (2%)* 17 (34.7%)
Transplantation time more than 5 yearas
Serum 25(OH) D (nmol/ml) 23.42±16.72 -
Transplantation time less than 5 yearas
Serum 25(OH) D (nmol/ml) 29.86±20.23 -
*P<0.05, statistically significant
Table 2: Relationship between 25-hydroxyvitamin D and independent
variable in linear logistic regression models
Unstandardized Coefficients
-------------------------------------------------
Parameters SE B p-value
Transplantation time (year) 11.35 -1.437 0.212
Age (year) 2.89 -0.358 0.212
BMI (kg/m ) 9.58 -0.508 0.5982
in  our  transplant   receivers,   mean   concentration  of
25-hydroxyvitamin D were lower than those healthy
people. In our study, we showed that kidney transplant
receivers are at high risk for vitamin D deficiency/
/insufficiency  and  have  significantly  lower  levels of
25-hydroxyvitamin D when compared with control
subjects. There is general unanimity that the
determination of serum 25-hydroxyvitamin D is the best
way that indicate vitamin D status [1]. The range values
for vitamin D deficiency/ insufficiency are
comprehensively discussable in the different studies,
principally due to differences in study populations and
the vitamin D assays used. The reasons of low 25-
hydroxyvitamin D levels are not completely clear. In these
patients, lack of vitamin D could be as a result of
decreased skin synthesis, losing by urine and elevated
metabolic breakdown of 25-hydroxyvitamin D. In this
study, we have not considered correlations of 25-
hydroxyvitamin D levels with variables such as
transplantation time, age and BMI. The results of our
study may need to compare to other countries. Because
of differences in the sunlight exposure, dressing habitual
in this area, not consuming vitamin D supplementation
and in the strengthening of milk products with vitamin D,
prologue in differences in vitamin D status between
different populations [24]. It could be concluded that
there is high prevalence of 25-hydroxyvitamin D
insufficiency and deficiency after kidney transplantation
(98% of our patients), without considering of
transplantation time. In accord with recent informs, we
suggest it very necessary that status of vitamin D
deficiency/insufficiency are corrected in kidney transplant
patients. Hence, supplementing of vitamin D appeared to
be the only possible ways of making better and correcting
vitamin D status in kidney transplant receivers.
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